Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 7
2004 5
2005 5
2006 6
2007 10
2008 6
2009 2
2010 7
2011 6
2012 12
2013 13
2014 13
2015 14
2016 13
2017 10
2018 14
2019 14
2020 20
2021 12
2022 13
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Cancer stem cell in breast cancer therapeutic resistance.
Bai X, Ni J, Beretov J, Graham P, Li Y. Bai X, et al. Among authors: graham p. Cancer Treat Rev. 2018 Sep;69:152-163. doi: 10.1016/j.ctrv.2018.07.004. Epub 2018 Jul 18. Cancer Treat Rev. 2018. PMID: 30029203 Review.
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA; BIG 3–07/TROG 07.01 trial investigators. Chua BH, et al. Among authors: graham ph. Lancet. 2022 Aug 6;400(10350):431-440. doi: 10.1016/S0140-6736(22)01246-6. Lancet. 2022. PMID: 35934006 Clinical Trial.
Regional Nodal Irradiation in Early-Stage Breast Cancer.
Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Chafe S, Nolan MC, Craighead P, Bowen J, McCready DR, Pritchard KI, Gelmon K, Murray Y, Chapman JA, Chen BE, Levine MN; MA.20 Study Investigators. Whelan TJ, et al. N Engl J Med. 2015 Jul 23;373(4):307-16. doi: 10.1056/NEJMoa1415340. N Engl J Med. 2015. PMID: 26200977 Free PMC article. Clinical Trial.
Exosomes in Cancer Radioresistance.
Ni J, Bucci J, Malouf D, Knox M, Graham P, Li Y. Ni J, et al. Among authors: graham p. Front Oncol. 2019 Sep 6;9:869. doi: 10.3389/fonc.2019.00869. eCollection 2019. Front Oncol. 2019. PMID: 31555599 Free PMC article. Review.
Exosomes and breast cancer drug resistance.
Dong X, Bai X, Ni J, Zhang H, Duan W, Graham P, Li Y. Dong X, et al. Among authors: graham p. Cell Death Dis. 2020 Nov 17;11(11):987. doi: 10.1038/s41419-020-03189-z. Cell Death Dis. 2020. PMID: 33203834 Free PMC article. Review.
Commutability and traceability in EQA programs.
Badrick T, Punyalack W, Graham P. Badrick T, et al. Among authors: graham p. Clin Biochem. 2018 Jun;56:102-104. doi: 10.1016/j.clinbiochem.2018.04.018. Epub 2018 Apr 20. Clin Biochem. 2018. PMID: 29684367 Review.
Targeting MicroRNAs in Prostate Cancer Radiotherapy.
Ni J, Bucci J, Chang L, Malouf D, Graham P, Li Y. Ni J, et al. Among authors: graham p. Theranostics. 2017 Jul 23;7(13):3243-3259. doi: 10.7150/thno.19934. eCollection 2017. Theranostics. 2017. PMID: 28900507 Free PMC article. Review.
Cancer stem cells in prostate cancer radioresistance.
Tsao T, Beretov J, Ni J, Bai X, Bucci J, Graham P, Li Y. Tsao T, et al. Among authors: graham p. Cancer Lett. 2019 Nov 28;465:94-104. doi: 10.1016/j.canlet.2019.08.020. Epub 2019 Sep 4. Cancer Lett. 2019. PMID: 31493443 Review.
197 results